Brexpiprazole for schizophrenia and as adjunct for major depressive disorder
Por um escritor misterioso
Descrição
Brexpiprazole in the Treatment of Major Depressive Disorder - Maryam I Al Shirawi, Nicole E Edgar, Sidney H Kennedy, 2017
Brexpiprazole for schizophrenia and as adjunct for major depressive disorder
Mechanism of action of brexpiprazole: comparison with aripiprazole, CNS Spectrums
The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors, Biology Direct
Journal Digest: Z-Drugs and Dementia; Methotrexate and Schizophrenia; Smartphones and Depression; Brexpiprazole and Sexual Function; E-Cigarettes and Youth; Opioids Deaths and Neighborhoods
Example rapid review: Brexpiprazole for schizophrenia v2 –
Rexulti (Brexpiprazole) for the Treatment of Major Depressive Disorder (MDD) and Schizophrenia - Clinical Trials Arena
PDF) Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study
Brexpiprazole in the Treatment of Major Depressive Disorder - Document - Gale OneFile: Health and Medicine
REXULTI® (brexpiprazole), MDD
Unipolar depression in adults: Choosing treatment for resistant depression - UpToDate
Full article: Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
de
por adulto (o preço varia de acordo com o tamanho do grupo)
